We produce a globally recognised, diversified and highly integrative portfolio of generic and specialty medicines concentrating towards a high range of chronic and acute treatments. Our product portfolio includes generics, branded generics, speciality, highly advanced technology intensive products, over the counter (OTC), Active Pharmaceutical Ingredients (APIs) Excipients, and intermediaries. Our global presence helps us in being receptive to local treatment needs while continually improving our global product offering.